Echo Street Capital Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Echo Street Capital Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-33,333	Closed	-$2K	–	691
2022 Q3	$2K	Hold	33,333	–	–	﹤0.01%	528
2022 Q2	$5K	Hold	33,333	–	–	﹤0.01%	532
2022 Q1	$10K	Hold	33,333	–	–	﹤0.01%	591
2021 Q4	$17K	Hold	33,333	–	–	﹤0.01%	597
2021 Q3	$18K	Buy	+33,333	New	+$24.4K	﹤0.01%	607

Other funds holding AEON.WS

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Echo Street Capital Management's AEON.WS Position: Q4 2022 in Review

Echo Street Capital Management sold out of AEON Biopharma Inc (AEON.WS) in Q4 2022, closing a stake of 33,333 shares — an estimated $2K sold.

Echo Street Capital Management first reported a position in AEON.WS in Q3 2021 and held it in 5 quarters. The position peaked at $18K in Q3 2021. 52 funds tracked by Wall St. Rank hold AEON.WS as of Q4 2022.

Echo Street Capital Management reported no remaining AEON Biopharma Inc position as of Q4 2022 after selling out during the quarter.
Echo Street Capital Management sold 33,333 AEON Biopharma Inc shares in Q4 2022, an estimated $2K.
Echo Street Capital Management first reported a position in AEON Biopharma Inc in Q3 2021 and held it in 5 quarters.
Echo Street Capital Management's AEON Biopharma Inc position peaked at $18K in Q3 2021.
52 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q4 2022.

Based on Echo Street Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.